However, our studies also revealed that high overexpression of SLC7A11 suppressed tumor metastasis, and CTCs exhibited lower SLC7A11 expression than did primary tumor samples from patients, which may seem counterintuitive in light of SLC7A11’s established tumor-promoting effect. This evidence concerns the gene SLC7A11 and neoplasm.